prospective randomized multicenter

Related by string. * prospectives . pro spective . PROSPECTIVE : Identify prospective partners . • Identify prospective . prospective groom / randomizing . randomizer . Randomized : randomized controlled trial . randomized controlled trials . randomized placebo controlled / Multicenter : multicenter Phase II . multicenter randomized double . Multicenter Randomized Double * *

Related by context. Frequent words. (Click for all words.) 75 double blinded placebo 74 multicenter randomized double 74 multicenter randomized 74 prospective multicenter 72 multicentre 71 Phase III randomized 70 placebo controlled randomized 70 active comparator 70 multicenter clinical 69 prospective randomized controlled 69 label multicenter 68 prospective randomized 68 prospective observational 68 Multicenter 68 placebo controlled clinical 67 phase IIa 67 randomized Phase III 66 Phase Ib clinical 66 multicenter 65 randomized controlled 65 randomized controlled clinical 65 blind randomized placebo 65 blind randomized controlled 64 placebo controlled studies 64 phase IIb 64 PRECISE 64 randomized placebo controlled 64 blind randomized 64 placebo controlled 63 randomized 63 Randomized 63 randomized clinical 63 Amrubicin 63 Thrombolysis 63 randomized double 63 blinded placebo controlled 63 TELCYTA 62 Rosuvastatin 62 TRITON TIMI 62 multicenter study 62 randomized controlled clinical trials 62 Apixaban 62 PREZISTA r 62 Phase 2b study 62 Phase 1b clinical 62 KRN# 62 non inferiority 62 noninferiority 61 dabigatran etexilate 61 nab paclitaxel 61 interferon beta 1b 61 PRECiSE 61 pharmacodynamic effects 61 phase 2a 61 irbesartan 61 RRMS patients 61 substudy 61 pertuzumab 61 dose escalation trial 61 ATTRACT 61 6R BH4 61 GSK# [001] 61 tanespimycin 61 Pivotal Trial 61 double blind placebo 61 Phase Ia 61 REVLIMID lenalidomide 60 Phase 2a clinical 60 Phase Ib 60 ischemic cardiomyopathy 60 Sym# 60 Pirfenidone 60 label dose escalation 60 subgroup analyzes 60 Phase IIa trial 60 placebo controlled trials 59 BAY #-# 59 BrachySil 59 Phase IIa clinical 59 SCH # 59 Phase 2a trial 59 unblinded 59 dose titration 59 elotuzumab 59 tolvaptan 59 MIRCERA 59 Phase 1b trial 59 administered subcutaneously 59 Pivotal Phase 59 liver transplant recipients 59 randomized #:# 59 anticancer compound 59 Phase IIb clinical 59 superficial bladder cancer 59 retrospective cohort study 59 Phase III Clinical Trial 59 Acute Myocardial Infarction 59 metastatic hormone refractory 59 intravenously administered 59 CR# vcMMAE 58 Carfilzomib

Back to home page